Rebecca Chambers
CFO at Veracyte, Inc. (VCYT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 4SEC | VCYTVeracyte, Inc. | Sell Plan | 2,477167,200 held (−1%) | $42.81 | $106K | +5.7% |
| Sep 4SEC | VCYTVeracyte, Inc. | Sell Plan | 1,175166,025 held (−1%) | $43.71 | $51K | +3.5% |
| Jun 4SEC | VCYTVeracyte, Inc. | Sell Plan | 1,600175,241 held (−1%) | $49.28 | $79K | -8.2% |
| Jun 4SEC | VCYTVeracyte, Inc. | Sell Plan | 1,961173,280 held (−1%) | $50.09 | $98K | -9.7% |
| Mar 6SEC | VCYTVeracyte, Inc. | Sell Plan | 4,400145,137 held (−3%) | $35.55 | $156K | +27.2% |
| Mar 6SEC | VCYTVeracyte, Inc. | Sell Plan | 13,941131,196 held (−10%) | $36.33 | $506K | +24.5% |
| Dec 4SEC | VCYTVeracyte, Inc. | Sell Plan | 8,537114,237 held (−7%) | $46.61 | $398K | -3.0% |
| Dec 4SEC | VCYTVeracyte, Inc. | Sell Plan | 4,741109,496 held (−4%) | $47.25 | $224K | -4.3% |
| Nov 7SEC | VCYTVeracyte, Inc. | Sell Plan | 7,000126,158 held (−5%) | $41.00 | $287K | +10.3% |
- Sell
CFO Rebecca Chambers sold $106K of VCYT at $42.81 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Rebecca Chambers sold $51K of VCYT at $43.71 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Rebecca Chambers sold $79K of VCYT at $49.28 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Rebecca Chambers sold $98K of VCYT at $50.09 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Rebecca Chambers sold $156K of VCYT at $35.55 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Rebecca Chambers sold $506K of VCYT at $36.33 — pre-scheduled 10b5-1 plan sale.